The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [v1; ref status: indexed, http://f1000r.es/20z]

Idiopathic inflammatory myopathies (IIM) belong to a group of autoimmune disorders, primarily characterized by chronic inflammation of human skeletal muscle tissue. The etiology of these diseases is unknown, however, genetic predisposition plays a significant role in disease onset. Beside the known...

Full description

Bibliographic Details
Main Authors: Martina Remakova, Tana Svitalkova, Marek Skoda, Jiri Vencovsky, Peter Novota
Format: Article
Language:English
Published: F1000 Research Ltd 2013-10-01
Series:F1000Research
Subjects:
Online Access:http://f1000research.com/articles/2-223/v1
_version_ 1818943331809361920
author Martina Remakova
Tana Svitalkova
Marek Skoda
Jiri Vencovsky
Peter Novota
author_facet Martina Remakova
Tana Svitalkova
Marek Skoda
Jiri Vencovsky
Peter Novota
author_sort Martina Remakova
collection DOAJ
description Idiopathic inflammatory myopathies (IIM) belong to a group of autoimmune disorders, primarily characterized by chronic inflammation of human skeletal muscle tissue. The etiology of these diseases is unknown, however, genetic predisposition plays a significant role in disease onset. Beside the known genetic risk located in the MHC complex, the epigenetic modifications including changes in miRNAs expression profiles have been recently implicated recently in many autoimmune diseases. Micro RNA molecules are involved in many physiological processes, including the regulation of the immune response. In our study we have focused on the miR-23b, as it represents a novel promising autoimmunity regulator molecule. Downregulation of miR-23b was recently described in patients with rheumatoid arthritis and systemic lupus erythematosus. We have measured the expression miR-23b peripheral blood mononuclear cells of patients with dermatomyositis and polymyositis. No meaningful difference was found in comparison with healthy controls.
first_indexed 2024-12-20T07:25:38Z
format Article
id doaj.art-9369f1b6adf344999b2de4e8512f4e66
institution Directory Open Access Journal
issn 2046-1402
language English
last_indexed 2024-12-20T07:25:38Z
publishDate 2013-10-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj.art-9369f1b6adf344999b2de4e8512f4e662022-12-21T19:48:33ZengF1000 Research LtdF1000Research2046-14022013-10-01210.12688/f1000research.2-223.v12627The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [v1; ref status: indexed, http://f1000r.es/20z]Martina Remakova0Tana Svitalkova1Marek Skoda2Jiri Vencovsky3Peter Novota4Department of Rheumatology, First Faculty of Medicine, Charles University in Prague and Rheumatology Institute, Prague, Czech RepublicDepartment of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech RepublicDepartment of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech RepublicDepartment of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech RepublicDepartment of Experimental and Clinical Rheumatology, Institute of Rheumatology, Prague, Czech RepublicIdiopathic inflammatory myopathies (IIM) belong to a group of autoimmune disorders, primarily characterized by chronic inflammation of human skeletal muscle tissue. The etiology of these diseases is unknown, however, genetic predisposition plays a significant role in disease onset. Beside the known genetic risk located in the MHC complex, the epigenetic modifications including changes in miRNAs expression profiles have been recently implicated recently in many autoimmune diseases. Micro RNA molecules are involved in many physiological processes, including the regulation of the immune response. In our study we have focused on the miR-23b, as it represents a novel promising autoimmunity regulator molecule. Downregulation of miR-23b was recently described in patients with rheumatoid arthritis and systemic lupus erythematosus. We have measured the expression miR-23b peripheral blood mononuclear cells of patients with dermatomyositis and polymyositis. No meaningful difference was found in comparison with healthy controls.http://f1000research.com/articles/2-223/v1Immune & Inflammatory Rheumatic Diseases (incl. Arthritis)Immunological Biomarkers
spellingShingle Martina Remakova
Tana Svitalkova
Marek Skoda
Jiri Vencovsky
Peter Novota
The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [v1; ref status: indexed, http://f1000r.es/20z]
F1000Research
Immune & Inflammatory Rheumatic Diseases (incl. Arthritis)
Immunological Biomarkers
title The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [v1; ref status: indexed, http://f1000r.es/20z]
title_full The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [v1; ref status: indexed, http://f1000r.es/20z]
title_fullStr The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [v1; ref status: indexed, http://f1000r.es/20z]
title_full_unstemmed The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [v1; ref status: indexed, http://f1000r.es/20z]
title_short The expression profile of miR-23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies [v1; ref status: indexed, http://f1000r.es/20z]
title_sort expression profile of mir 23b is not altered in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies v1 ref status indexed http f1000r es 20z
topic Immune & Inflammatory Rheumatic Diseases (incl. Arthritis)
Immunological Biomarkers
url http://f1000research.com/articles/2-223/v1
work_keys_str_mv AT martinaremakova theexpressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT tanasvitalkova theexpressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT marekskoda theexpressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT jirivencovsky theexpressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT peternovota theexpressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT martinaremakova expressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT tanasvitalkova expressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT marekskoda expressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT jirivencovsky expressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z
AT peternovota expressionprofileofmir23bisnotalteredinperipheralbloodmononuclearcellsofpatientswithidiopathicinflammatorymyopathiesv1refstatusindexedhttpf1000res20z